TECH OFFER

Inhaled Therapeutic for Treatment of Chronic Obstructive Pulmonary Disease

KEY INFORMATION

TECHNOLOGY CATEGORY:
Healthcare - Pharmaceuticals & Therapeutics
TECHNOLOGY READINESS LEVEL (TRL):
LOCATION:
Singapore
ID NUMBER:
TO129309

TECHNOLOGY OVERVIEW

Chronic obstructive pulmonary disease (COPD) is a progressive life-threatening inflammatory lung disease characterized by chronic bronchitis (inflamed airways) and emphysema (irreversible lung tissue destruction). It is the most prevalent chronic lung disease, affecting more than 300 million people worldwide and is the 3rd leading cause of death globally. The prevalence of COPD is set to rise due to worsening air pollution, increased smoking and an aging population.

Currently, the existing treatment options such as bronchodilators or corticosteroids only relieve disease symptoms but do not control lung tissue damage or stop disease progression. Hence, there is an urgent unmet medical need to develop effective therapies for COPD. The technology developed would be able to halt COPD disease progression.

TECHNOLOGY FEATURES & SPECIFICATIONS

The current invention relates to a protein therapeutic that can quench lung inflammation by inducing cell death of lung alveolar macrophages, the main airway immune cells responsible for COPD. The protein therapeutic binds to a receptor on the macrophage to trigger apoptosis. The reduction in macrophage cell number in the lung facilitates the recovery of lung function.

Pulmonary delivery of this protein has been demonstrated to block COPD progression and restore lung function in chronic cigarette smoke-induced COPD mice.

Additional studies are being done to evaluate the efficacy of the protein therapeutic in other lung inflammatory diseases such as asthma and fibrosis.

Priority patent filed in March 2018.

POTENTIAL APPLICATIONS

  • Novel target for COPD, first-in-class
  • Novel biological mechanism to control tissue damage in COPD, efficacy demonstrated in mice model
  • Able to halt disease progression and restore lung function
  • Targets the alveolar macrophages which constitute 95% of immune cells in air sac and plays a dominant role in COPD pathology.
  • Effective by topical lung delivery

Benefits

COPD is a chronic inflammatory lung disease. Symptoms include breathing difficulty, cough, accumulation of mucus and wheezing. Current treatment options only provide relief of the disease symptoms. Our technology stops disease progression, thereby resulting in improvement in quality of life.

RELATED TECH OFFERS
Therapeutic Inhibitor for Epstein-Barr Virus (EBV)-associated Cancers
Cancer Catcher - Early Detection of Circulating Tumour Cells
Potent Anti-bacterial Plant Oil for Skin Health and Ailment
Melanin Derived From Black Soldier Flies
Non-Invasive, Non-Toxic Encapsulation Technology to Prolong Effects of Leave-on Products
Novel Anti-microbial Agent for Preventing Dental Caries
Growth Factor-free Proliferation & Differentiation of Stem Cell
A modified Chinese Medicine formulation for treating Alzheimer's disease
Plant-Harvested Biopolymer for Postsurgical Adhesion Barrier Gel and Film Application
Nano-vesicles for Improving Drug’s Stability and Efficacy to Treat Chronic Diseases